Northlane Capital Partners, a private equity firm in Bethesda, Maryland, completed the investment in SAI MedPartners, a consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries. Financial terms were not disclosed. "We are thrilled to partner with NCP, which has an impressive track record of investing in businesses that support the pharmaceutical and medical device industries. SAI’s rapid organic growth over the past decade has been driven by a singular focus on being the best thought partner and provider of high-quality strategic intelligence and related advisory services to our clients. NCP’s investment will allow us to further strengthen our client engagement model by providing us with the resources to significantly augment our suite of services and continue to expand globally," Erik Nordhoy, SAI Founder and CEO.